ESPR vs. ARKF
ESPR (Esperion Therapeutics, Inc.) is a stock, while ARKF (ARK Fintech Innovation ETF) is Blockchain fund actively managed by ARK. Over the past 5 years, ESPR returned -29.19%/yr vs -4.30%/yr for ARKF. At a 0.28 correlation, their price movements are largely independent.
Performance
ESPR vs. ARKF - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ESPR achieves a -14.05% return, which is significantly lower than ARKF's -13.25% return.
ESPR
- 1D
- 0.00%
- 1M
- 0.95%
- 6M
- -10.42%
- YTD
- -14.05%
- 1Y
- 167.23%
- 3Y*
- 30.22%
- 5Y*
- -29.19%
- 10Y*
- -11.79%
ARKF
- 1D
- -0.74%
- 1M
- 6.19%
- 6M
- -16.15%
- YTD
- -13.25%
- 1Y
- -18.91%
- 3Y*
- 20.97%
- 5Y*
- -4.30%
- 10Y*
- —
ESPR vs. ARKF - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
ESPR Esperion Therapeutics, Inc. | -14.05% | 68.18% | -26.42% | -52.01% | 24.60% | -80.77% | -56.40% | 28.68% |
ARKF ARK Fintech Innovation ETF | -13.25% | 28.67% | 34.34% | 93.27% | -65.07% | -17.82% | 108.03% | 20.45% |
Correlation
The correlation between ESPR and ARKF is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.30 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Feb 4, 2019 | 0.28 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ESPR vs. ARKF — Risk / Return Rank
ESPR
ARKF
ESPR vs. ARKF - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Esperion Therapeutics, Inc. (ESPR) and ARK Fintech Innovation ETF (ARKF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ESPR | ARKF | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.43 | ||
| Sortino ratioReturn per unit of downside risk | +3.56 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 0.93 | +0.46 |
| Calmar ratioReturn relative to maximum drawdown | 3.16 | -0.49 | +3.66 |
| Martin ratioReturn relative to average drawdown | 7.64 | -0.83 | +8.47 |
Loading charts...
Drawdowns
ESPR vs. ARKF - Drawdown Comparison
The maximum ESPR drawdown since its inception was -99.37%, which is greater than ARKF's maximum drawdown of -78.63%. Use the drawdown chart below to compare losses from any high point for ESPR and ARKF.
Loading charts...
Drawdown Indicators
| ESPR | ARKF | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.37% | -78.63% | -20.74% |
Max Drawdown (1Y)Largest decline over 1 year | -53.19% | -38.50% | -14.69% |
Max Drawdown (3Y)Largest decline over 3 years | -80.94% | -38.50% | -42.44% |
Max Drawdown (5Y)Largest decline over 5 years | -95.93% | -75.30% | -20.63% |
Max Drawdown (10Y)Largest decline over 10 years | -99.10% | — | — |
Current DrawdownCurrent decline from peak | -97.24% | -34.97% | -62.27% |
Average DrawdownAverage peak-to-trough decline | -70.15% | -34.97% | -35.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.98% | 22.71% | -0.73% |
Volatility
ESPR vs. ARKF - Volatility Comparison
The current volatility for Esperion Therapeutics, Inc. (ESPR) is 1.75%, while ARK Fintech Innovation ETF (ARKF) has a volatility of 8.81%. This indicates that ESPR experiences smaller price fluctuations and is considered to be less risky than ARKF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ESPR | ARKF | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.75% | 8.81% | -7.06% |
Volatility (6M)Calculated over the trailing 6-month period | 59.70% | 25.64% | +34.06% |
Volatility (1Y)Calculated over the trailing 1-year period | 90.39% | 33.71% | +56.68% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 91.65% | 42.98% | +48.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 83.40% | 39.68% | +43.72% |
Dividends
ESPR vs. ARKF - Dividend Comparison
ESPR has not paid dividends to shareholders, while ARKF's dividend yield for the trailing twelve months is around 0.10%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
ARKF ARK Fintech Innovation ETF | 0.10% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.37% | 1.25% |
ESPR Esperion Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
ESPR and ARKF have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKF has higher volatility (8.81%) compared to ESPR (1.75%). In terms of maximum drawdown, ESPR dropped -99.37% vs ARKF's -78.63%.
ESPR currently has the higher Sharpe Ratio (1.87 vs -0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ESPR and ARKF
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer